CRP testing aids coronavirus management in China
![CRP testing aids coronavirus management in China](https://paltry-paradoxure.transforms.svdcdn.com/production/general/Images/Brand-images/Aidian/Aidian_brand_image_18_RGB_CUT.png?w=768&h=465&q=60&auto=format&fit=crop&dm=1573827589&s=8702cdf7f4bd8bff53b3df09b6f3af5c 768w, https://paltry-paradoxure.transforms.svdcdn.com/production/general/Images/Brand-images/Aidian/Aidian_brand_image_18_RGB_CUT.png?w=576&h=348&q=60&auto=format&fit=crop&dm=1573827589&s=74781dc7685a78ffe7680c42ae878775 576w)
Although there are very limited available research data, currently spreading novel coronavirus (2019-nCoV) seems to increase C-reactive protein (CRP) levels significantly, due to viral alveolar damage that was also seen in the SARS epidemic in 2002. General Office of the Chinese National Health Commission has released a guideline to guide the diagnosis and treatment of 2019-nCoV recommending the use of CRP tests together with other clinical parameters for evaluation and follow-up of coronavirus infection.
Aidian participates in the fight against the coronavirus outbreak by providing cost-efficient CRP test solutions for the management of infection in China. QuikRead go CRP point-of-care tests provide fast and reliable test results that can be immediately used for making decisions about the patient’s management.